Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
CC transcript
|
|
Rosetta Genomics Ltd. (ROSG)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/22/2019 |
4
| SABBY MANAGEMENT, LLC (10% Owner) has filed a Form 4 on Rosetta Genomics Ltd. |
| 01/04/2019 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 15.9% stake in Rosetta Genomics Ltd |
| 07/19/2018 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 06/07/2018 |
SC 13G/A
| MORGAN STANLEY reports a 0% stake in Rosetta Genomics Ltd. |
| 05/18/2018 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 05/01/2018 |
NT 20-F
| Form NT 20-F - Notification of inability to timely file Form 20-F: |
| 04/27/2018 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 04/26/2018 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 04/19/2018 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 04/19/2018 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 04/17/2018 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 04/10/2018 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 04/10/2018 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 04/05/2018 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 03/19/2018 |
4
| SABBY MANAGEMENT, LLC (10% Owner) has filed a Form 4 on Rosetta Genomics Ltd.|
Txns:
| Bought 1,400 shares
@ $0.4211, valued at
$589.5
Bought 20,229 shares
@ $0.4261, valued at
$8.6k
Bought 9,247 shares
@ $0.4294, valued at
$4k
Bought 33,413 shares
@ $0.4353, valued at
$14.5k
Bought 9 shares
@ $0.4201, valued at
$3.8 |
|
| 03/16/2018 |
4
| SABBY MANAGEMENT, LLC (10% Owner) has filed a Form 4 on Rosetta Genomics Ltd.|
Txns:
| Bought 800 shares
@ $0.4199, valued at
$335.9
Bought 4,271 shares
@ $0.42, valued at
$1.8k
Bought 200 shares
@ $0.42, valued at
$84
Bought 17,900 shares
@ $0.424, valued at
$7.6k
Bought 50,020 shares
@ $0.4201, valued at
$21k
Bought 15,025 shares
@ $0.4205, valued at
$6.3k
Bought 34 shares
@ $0.42, valued at
$14.3
Bought 3,566 shares
@ $0.42, valued at
$1.5k
Bought 13,545 shares
@ $0.42, valued at
$5.7k
Bought 14,400 shares
@ $0.4205, valued at
$6.1k
|
|
| 03/14/2018 |
4
| SABBY MANAGEMENT, LLC (10% Owner) has filed a Form 4 on Rosetta Genomics Ltd.|
Txns:
| Bought 20,373 shares
@ $0.4199, valued at
$8.6k
Bought 454 shares
@ $0.401, valued at
$182.1
Bought 2,604 shares
@ $0.4199, valued at
$1.1k
Bought 11,521 shares
@ $0.41, valued at
$4.7k
Bought 21,800 shares
@ $0.4117, valued at
$9k
Bought 24,600 shares
@ $0.4185, valued at
$10.3k
Bought 24,162 shares
@ $0.4186, valued at
$10.1k
Bought 10,605 shares
@ $0.4189, valued at
$4.4k
Bought 12,390 shares
@ $0.4101, valued at
$5.1k
Bought 10,000 shares
@ $0.42, valued at
$4.2k
Bought 30,990 shares
@ $0.4203, valued at
$13k
|
|
| 03/14/2018 |
3
| SABBY MANAGEMENT, LLC (10% Owner) has filed a Form 3 on Rosetta Genomics Ltd. |
| 03/13/2018 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:|
Docs:
|
"Proxy statement relating to the extraordinary general meeting of shareholders of Rosetta Genomics Ltd. to be held on April 17, 2018",
"Proxy statement relating to the extraordinary general meeting of shareholders of Rosetta Genomics Ltd. to be held on April 17, 2018",
"Proxy card relating to the extraordinary general meeting of shareholders of Rosetta Genomics Ltd. to be held on April 17, 2018",
"Agreement and Plan of Merger by and among Genoptix, Inc., Stone Marger Sub Ltd., and Rosetta Genomics Ltd.",
"Amendment Number One to the Merger Agreement",
"Amendment Number One to the Loan and Security Agreement",
"Amendment Number Two to the Loan and Security Agreement",
"Expense Reimbursement Waiver Agreement by and among Genoptix, Inc. and Rosetta Genomics Ltd.",
"Amendment Number One to the Expense Reimbursement and Waiver Agreement" |
|
| 03/12/2018 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 5.9% stake in Rosetta Genomics Ltd |
| 03/12/2018 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 03/06/2018 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 02/27/2018 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 02/23/2018 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 02/16/2018 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 02/15/2018 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 02/12/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2018 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 01/22/2018 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 12/28/2017 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 12/27/2017 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 12/22/2017 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 12/21/2017 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:|
Docs:
|
"6-K",
"Agreement and Plan of Merger, by and among the Company, Genoptix, Inc., and Stone Merger Sub Ltd.",
"Loan and Security Agreement, by and among the Company, Genoptix, Inc., Minuet Diagnostics, Inc., Cynogen Inc. and Rosetta Genomics Inc.",
"Genoptix to Acquire Rosetta Genomics for $10 Million in Cash" |
|
| 12/13/2017 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
|
|
|